Literature DB >> 18602961

Effects of a large-scale introduction of the pneumococcal polysaccharide vaccine among elderly persons in Stockholm, Sweden.

Carl Spindler1, Jonas Hedlund, Aftab Jasir, Birgitta Henriques Normark, Ake Ortqvist.   

Abstract

In October 1998 Stockholm County launched a 3-year vaccination campaign with the 23-valent pneumococcal polysaccharide vaccine (PPV-23) directed towards all elderly persons. We analysed the impact of this campaign on the incidence and serotype distribution of invasive pneumococcal disease (IPD) in Stockholm County, where the vaccine coverage was 36%, as compared to Skåne County, where no vaccination campaign was performed. The incidence of vaccine-type IPD in Stockholm declined significantly during the study period (1997-2001) in elderly persons, from 50 to 28.9/100,000, but not in other age groups in Stockholm, nor in any age group in Skåne.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18602961     DOI: 10.1016/j.vaccine.2008.06.073

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

2.  Streptococcus pyogenes bacteraemia, emm types and superantigen profiles.

Authors:  S Rantala; S Vähäkuopus; T Siljander; J Vuopio; H Huhtala; R Vuento; J Syrjänen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-30       Impact factor: 3.267

3.  Pneumococcal vaccination coverages among low-, intermediate-, and high-risk adults in Catalonia.

Authors:  Angel Vila-Corcoles; Olga Ochoa-Gondar; Imma Hospital; Cinta de Diego; Eva Satué; Jordi Bladé; Xabier Ansa; Jorge A Guzmán; Elisabet Salsench; Francisca Ramos
Journal:  Hum Vaccin Immunother       Date:  2016-07-25       Impact factor: 3.452

4.  Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe.

Authors:  Bogdan Luca-Harari; Jessica Darenberg; Shona Neal; Tuula Siljander; Lenka Strakova; Asha Tanna; Roberta Creti; Kim Ekelund; Maria Koliou; Panayotis T Tassios; Mark van der Linden; Monica Straut; Jaana Vuopio-Varkila; Anne Bouvet; Androulla Efstratiou; Claes Schalén; Birgitta Henriques-Normark; Aftab Jasir
Journal:  J Clin Microbiol       Date:  2009-01-21       Impact factor: 5.948

5.  Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; Navneet Singh; Narayan Mishra; G C Khilnani; J K Samaria; S N Gaur; S K Jindal
Journal:  Lung India       Date:  2012-07

6.  Pneumococcal vaccination coverages by age, sex and specific underlying risk conditions among middle-aged and older adults in Catalonia, Spain, 2017.

Authors:  Angel Vila-Córcoles; Olga Ochoa-Gondar; Cinta de Diego; Eva Satué; Angel Vila-Rovira; Maria Aragón
Journal:  Euro Surveill       Date:  2019-07

Review 7.  Insights Into the Effects of Mucosal Epithelial and Innate Immune Dysfunction in Older People on Host Interactions With Streptococcus pneumoniae.

Authors:  Caroline M Weight; Simon P Jochems; Hugh Adler; Daniela M Ferreira; Jeremy S Brown; Robert S Heyderman
Journal:  Front Cell Infect Microbiol       Date:  2021-05-25       Impact factor: 5.293

8.  A nurse-delivered brief health education intervention to improve pneumococcal vaccination rate among older patients with chronic diseases: a cluster randomized controlled trial.

Authors:  Sophia S C Chan; Doris Y P Leung; Angela Y M Leung; Cindy Lam; Ivan Hung; Daniel Chu; Chi Kuen Chan; Janice Johnston; Shao Haei Liu; Raymond Liang; Tai Hing Lam; Kwok Yung Yuen
Journal:  Int J Nurs Stud       Date:  2014-06-19       Impact factor: 5.837

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.